|
Volumn 84, Issue 3, 2014, Pages 537-541
|
Translating human genetics into novel treatment targets for schizophrenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
PROTEIN KINASE B;
CACNA1C GENE;
CACNA1D GENE;
CACNB2 GENE;
CALCIUM SIGNALING;
DISEASE ASSOCIATION;
DOPAMINE RECEPTOR BLOCKING;
DRD2 GENE;
EXOME;
GENE;
GENE EXPRESSION REGULATION;
GENE LINKAGE DISEQUILIBRIUM;
GENETIC ANALYSIS;
GENETIC ASSOCIATION;
GENOME ANALYSIS;
HISTOCOMPATIBILITY COMPLEX;
HUMAN;
MUTATIONAL ANALYSIS;
NERVE CELL PLASTICITY;
NEUROMODULATION;
NONHUMAN;
QUANTITATIVE TRAIT LOCUS;
RNA SPLICING;
SCHIZOPHRENIA;
SEQUENCE ANALYSIS;
SHORT SURVEY;
SINGLE NUCLEOTIDE POLYMORPHISM;
ANIMAL;
DRUG DEVELOPMENT;
GENETIC PREDISPOSITION;
GENETICS;
MEDICAL GENETICS;
PROCEDURES;
TRANSLATIONAL RESEARCH;
ANIMALS;
DRUG DISCOVERY;
GENETIC PREDISPOSITION TO DISEASE;
GENETICS, MEDICAL;
HUMANS;
SCHIZOPHRENIA;
TRANSLATIONAL MEDICAL RESEARCH;
|
EID: 84912091480
PISSN: 08966273
EISSN: 10974199
Source Type: Journal
DOI: 10.1016/j.neuron.2014.10.037 Document Type: Short Survey |
Times cited : (23)
|
References (18)
|